18F-PSMA-1007 Uptake in Paget Disease of the Bone: An "Iron Man" Sign

Clin Nucl Med. 2022 Mar 1;47(3):249-250. doi: 10.1097/RLU.0000000000003867.

Abstract

18F-PSMA is a promising tracer for both staging and detection of biochemical recurrence in prostate cancer. PSMA is also expressed in the benign pathological conditions. We report a case of 81-year-old man with a known case of prostate cancer who underwent 18F-PSMA for restaging. 18F-PSMA PET/CT shows intense tracer uptake in the frontal bone appearing like an "Iron Man" sign. Corresponding noncontrast CT images, pagetoid changes with thickened cortex, mixed lytic/sclerotic mottled pattern. It is important to recognize 18F-PSMA expression in the benign nonprostatic pathologies to avoid false interpretation.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Edetic Acid
  • Gallium Radioisotopes
  • Humans
  • Male
  • Niacinamide* / analogs & derivatives
  • Oligopeptides*
  • Osteitis Deformans / diagnostic imaging*
  • Positron Emission Tomography Computed Tomography*
  • Prostatic Neoplasms / diagnostic imaging
  • Radiopharmaceuticals

Substances

  • Gallium Radioisotopes
  • Oligopeptides
  • PSMA-1007
  • Radiopharmaceuticals
  • Niacinamide
  • Edetic Acid